Investigation Report on China's Capecitabine Market 2021-2025

Publisher Name :
Date: 19-Jul-2021
No. of pages: 50

Capecitabine is a pyrimidine analog (pentoxycarbonyl-deoxy-cytosine nucleoside) that has anti-tumor activity to inhibit a variety of solid tumors, including breast and colon cancer. Capecitabine was developed by Roche. Its product, XELODA was approved to enter the Chinese market in 2001. By 2020, there are several manufacturers in the Capecitabine market in China.

According to CRI's market research, the sales of Capecitabine in the Chinese market increased year by year from 2016 to 2019. Due to the impact of the COVID-19 pandemic on the hospital's overall diagnosis and treatment services, sales in 2020 decreased to CNY 914 million, a year-on-year decrease of 9.31%. The CAGR of Capecitabine sales in the Chinese market from 2016 to 2020 is 1.21%.

CRI expects that with the easing of the COVID-19 pandemic, the sales of Capecitabine in the Chinese market will have a restorative growth in 2021-2025. In 2020, the number of COVID-19 breast cancers worldwide reached 2.26 million, and the number of colon cancers reached 1.93 million, both of which were on the rise. The number of breast and colon cancers in China will be also on the rise in the future. Therefore, the sales volume of Capecitabine, which is used to inhibit the anti-tumor activity of a variety of solid tumors, will increase with the increase in the number of breast cancer and colon cancer patients in China. There is also room for sales to rise. In addition, by the end of 2020, a number of companies led by Chengdu Yuandong Biopharmaceuticals have already reported for Capecitabine generic drug approval. In the next few years, more manufacturers will join the Chinese market. The sales volume and sales of Capecitabine in China are expected to rise.

 

Topics Covered:

  • The impact of COVID-19 on China's Capecitabine market
  • Sales value of China's Capecitabine 2016-2020
  • Competitive landscape of China's Capecitabine market
  • Prices of Capecitabine in China
  • Prices of Capecitabine in China by regions and manufacturers
  • Analysis on factors affecting the development of China's Capecitabine market
  • Prospect of China's Capecitabine market from 2021 to 2025

Investigation Report on China's Capecitabine Market 2021-2025

Table of Contents

1 Relevant Concepts of Capecitabine   


  • 1.1 Indications for Capecitabine   

  • 1.2 Development history of Capecitabine in China     

  • 1.3 Approval Information of Capecitabine in China

  • 1.4 The Impact of COVID-19 on Capecitabine sales in China


 


2 Sales of Capecitabine in China, 2016-2020


  • 2.1 Sales Value of Capecitabine   

  • 2.1.1 Overall Sales Value

  • 2.1.2 Sales Value by Region 

  • 2.2 Sales Volume of Capecitabine

  • 2.2.1 Overall Sales Volume  

  • 2.2.2 Sales Volume by Region     

  • 2.3 Sales of Capecitabine by Dosage Form in China, 2016-2020

  • 2.3.1 Tablets

  • 2.3.2 Analysis of Other Dosage Forms


      


3 Analysis of Major Capecitabine Manufacturers in China, 2016-2020     


  • 3.1 Market Share Analysis of Major Capecitabine Manufacturers

  • 3.1.1 Market Share by Sales Value

  • 3.1.2 Market Share by Sales Volume   

  • 3.2 Shanghai Roche Pharmaceuticals Co., Ltd.   

  • 3.2.1 Enterprise Profile 

  • 3.2.2 Sales of XELODA (Shanghai Roche Pharmaceuticals Co., Ltd.’s Capecitabine) in China

  • 3.3  Jiangsu Heng Rui Pharmaceutical Co., Ltd.

  • 3.3.1 Enterprise Profile 

  • 3.3.2 Sales of Aibin (Jiangsu Hengrui Medicine Co,.Ltd.’s Capecitabine) in China

  • 3.4 Qilu Pharmaceutical Co., Ltd.

  • 3.4.1 Enterprise Profile 

  • 3.4.2 Sales of Zuolun (Qilu Pharmaceutical Co., Ltd. ’s Capecitabine) in China

  • 3.5 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

  • 3.5.1 Enterprise Profile 

  • 3.5.2 Sales of Shoufu (Chia Tai Tianqing Pharmaceutical Group Co., Ltd.’s Capecitabine) in China

  • 3.6 Hoffmann-La Roche Inc

  • 3.6.1 Enterprise Profile 

  • 3.6.2 Sales of XELODA (Hoffmann-La Roche Inc’s Capecitabine) in China


 


4 Prices of Capecitabine of Different Manufacturers in China, 2020-2021


  • 4.1 Shanghai Roche Pharmaceuticals Co., Ltd. (XELODA)

  • 4.2 Jiangsu Hengrui Medicine Co,.Ltd. (Aibin)

  • 4.3 Qilu Pharmaceutical Co., Ltd. (Zuolun)

  • 4.4 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (Shoufu)

  • 4.5 Hoffmann-La Roche Inc (XELODA)


 


5 Prospect of Chinese Capecitabine drug Market, 2021-2025


  • 5.1 Influential Factors of Chinese Capecitabine Market Development

  • 5.1.1 The Impact of COVID-19 on Chinese Capecitabine Market

  • 5.1.2 Market Drivers and Opportunities

  • 5.1.3 Market Threats and Challenges

  • 5.2 Forecast on Market Size 

  • 5.3 Forecast on Market Trend

  •  


List of Charts


  • Chart Patent Information About Capecitabine Tablets Registration in China

  • Chart Sales Value of Capecitabine Tablets over the World  

  • Chart Sales Value of Capecitabine Tablets in China, 2016-2020 

  • Chart Sales Value of Capecitabine Tablets in China by Region, 2016-2020

  • Chart Sales Volume of Capecitabine Tablets in China, 2016-2020     

  • Chart Sales Volume of Capecitabine Tablets in China by Region, 2016-2020

  • Chart Market Share by Sales Value of Top Capecitabine Manufacturers in China, 2016-2020

  • Chart Sales Value and Volume of XELODA (Shanghai Roche Pharmaceuticals Co., Ltd.’s Capecitabine) in China, 2016-2020     

  • Chart Sales Value and Volume of Aibin in China, 2016-2020

  • Chart Sales Value and Volume of Zuolun in China, 2016-2020  

  • Chart Sales Value and Volume of Shoufu in China, 2016-2020   

  • Chart Sales Value and Volume of XELODA (Hoffmann-La Roche Inc’s Capecitabine) in China, 2016-2020           

  • Chart Referential Prices of XELODA (Shanghai Roche Pharmaceuticals Co., Ltd.’s Capecitabine) in China, 2020-2021     

  • Chart Referential Prices of Aibin in China, 2020-2021        

  • Chart Referential Prices of Zuolun in China, 2020-2021           

  • Chart Referential Prices of Shoufu in China, 2020-2021     

  • Chart Referential Prices of XELODA (Hoffmann-La Roche Inc’s Capecitabine) in China, 2020-2021

  • Chart Forecast on Sales Value of Capecitabine in China, 2021-2025

  • Chart Forecast on Sales Volume of Capecitabine in China, 2021-2025 

  • Global 5-Fluorouracil Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76
    The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
  • Global Carboplatin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
  • Global Neutropenia Drugs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
  • Global Small Molecule Cancer Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
  • Global Capecitabine Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
  • Global Oxaliplatin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
  • Global Cancer Treatment Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
  • Global Capecitabine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Methotrexate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs